255 related articles for article (PubMed ID: 26306861)
1. Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects.
Titz B; Sewer A; Schneider T; Elamin A; Martin F; Dijon S; Luettich K; Guedj E; Vuillaume G; Ivanov NV; Peck MJ; Chaudhary NI; Hoeng J; Peitsch MC
J Proteomics; 2015 Oct; 128():306-20. PubMed ID: 26306861
[TBL] [Abstract][Full Text] [Related]
2. Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids.
Telenga ED; Hoffmann RF; Ruben t'Kindt ; Hoonhorst SJ; Willemse BW; van Oosterhout AJ; Heijink IH; van den Berge M; Jorge L; Sandra P; Postma DS; Sandra K; ten Hacken NH
Am J Respir Crit Care Med; 2014 Jul; 190(2):155-64. PubMed ID: 24871890
[TBL] [Abstract][Full Text] [Related]
3. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
Kałucka S
Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
[TBL] [Abstract][Full Text] [Related]
4. Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
Weidner J; Jarenbäck L; de Jong K; Vonk JM; van den Berge M; Brandsma CA; Boezen HM; Sin D; Bossé Y; Nickle D; Ankerst J; Bjermer L; Postma DS; Faiz A; Tufvesson E
Respir Res; 2017 May; 18(1):77. PubMed ID: 28464818
[TBL] [Abstract][Full Text] [Related]
5. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
[TBL] [Abstract][Full Text] [Related]
6. Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD.
Ohlmeier S; Mazur W; Linja-Aho A; Louhelainen N; Rönty M; Toljamo T; Bergmann U; Kinnula VL
J Proteome Res; 2012 Feb; 11(2):599-608. PubMed ID: 22053820
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects.
Malerba M; Ragnoli B; Corradi M
Monaldi Arch Chest Dis; 2008 Sep; 69(3):128-33. PubMed ID: 19065847
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
Zhang L; Cheng Z; Liu W; Wu K
COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
[TBL] [Abstract][Full Text] [Related]
10. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD.
Rytilä P; Rehn T; Ilumets H; Rouhos A; Sovijärvi A; Myllärniemi M; Kinnula VL
Respir Res; 2006 Apr; 7(1):69. PubMed ID: 16646959
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.
Van Pottelberge GR; Mestdagh P; Bracke KR; Thas O; van Durme YM; Joos GF; Vandesompele J; Brusselle GG
Am J Respir Crit Care Med; 2011 Apr; 183(7):898-906. PubMed ID: 21037022
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
[TBL] [Abstract][Full Text] [Related]
13. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
[TBL] [Abstract][Full Text] [Related]
14. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
[TBL] [Abstract][Full Text] [Related]
15. Comparison assessment methods of smoking consequences use in primary care.
Kałucka S
Przegl Lek; 2009; 66(10):822-9. PubMed ID: 20301946
[TBL] [Abstract][Full Text] [Related]
16. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers.
Singh D; Fox SM; Tal-Singer R; Plumb J; Bates S; Broad P; Riley JH; Celli B;
Thorax; 2011 Jun; 66(6):489-95. PubMed ID: 21441172
[TBL] [Abstract][Full Text] [Related]
17. Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: a longitudinal study.
Gao J; Ohlmeier S; Nieminen P; Toljamo T; Tiitinen S; Kanerva T; Bingle L; Araujo B; Rönty M; Höyhtyä M; Bingle CD; Mazur W; Pulkkinen V
Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L17-26. PubMed ID: 25979078
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers.
Willemse BW; ten Hacken NH; Rutgers B; Lesman-Leegte IG; Postma DS; Timens W
Eur Respir J; 2005 Nov; 26(5):835-45. PubMed ID: 16264044
[TBL] [Abstract][Full Text] [Related]
19. Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.
Ishikawa N; Mazur W; Toljamo T; Vuopala K; Rönty M; Horimasu Y; Kohno N; Kinnula VL
BMC Pulm Med; 2011 May; 11():22. PubMed ID: 21569324
[TBL] [Abstract][Full Text] [Related]
20. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
